Enterprise Value

776M

Cash

739.2M

Avg Qtr Burn

-76.73M

Short % of Float

10.54%

Insider Ownership

1.35%

Institutional Own.

-

Qtr Updated

03/31/23


Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & IndicationStage & EventCatalyst Date

Approved

Quarterly sales

Approved

Quarterly sales

Phase 3

Data readout

Phase 3

Data readout

Phase 3

Update

Phase 2

Data readout

AG-946 Details
Myelodysplastic syndrome

Phase 2a

Data readout